David Ubben

Dihydroartemisinin-Piperaquine and Artemether-Lumefantrine for Treating Uncomplicated Malaria in African Children: A Randomised, Non-Inferiority Trial

Quique Bassat, Modest Mulenga, Halidou Tinto et al. · PLoS ONE · 2009 · 161 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trial

Salim Abdulla, Issaka Sagara, Steffen Borrmann et al. · The Lancet · 2008 · 139 citations

Medicine, Pediatrics, Pharmacology +15

Tn1721 derivatives for transposon mutagenesis, restriction mapping and nucleotide sequence analysis

David Ubben, Rüdiger Schmitt · Gene · 1986 · 119 citations

Life Sciences, Genetics, Molecular Genetics +15

Contrasting benefits of different artemisinin combination therapies as first-line malaria treatments using model-based cost-effectiveness analysis

Lucy Okell, Matthew Cairns, Jamie T. Griffin et al. · Nature Communications · 2014 · 108 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacology +17

An Open-Label, Randomised Study of Dihydroartemisinin-Piperaquine Versus Artesunate-Mefloquine for Falciparum Malaria in Asia

Neena Valecha, Aung Pyae Phyo, Mayfong Mayxay et al. · PLoS ONE · 2010 · 98 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16